; and (B) ensure that such information is updated not less frequently than annually. (2) Information described For purposes of paragraph (1), the information described in this paragraph is, with respect to an applicable laboratory and a specified clinical diagnostic laboratory test, the following: (A) The discounted cash price for such test (or, if no such price exists, the gross charge for such test). (B) The deidentified minimum payer-specific negotiated charge between such laboratory and any third party payer for such test. (C) The deidentified maximum payer-specific negotiated charge between such laboratory and any third party payer for such test. (3) Uniform method and format Not later than January 1, 2026, the Secretary shall establish a standard, uniform method and format for applicable laboratories to use in compiling and making public information pursuant to paragraph (1). Such method and format— (A) may be similar to any template made available by the Centers for Medicare & Medicaid Services (as described in section 1899C(a)(2)(C)(ii)); (B) shall meet such standards as determined appropriate by the Secretary in order to ensure the accessibility and usability of such information; and (C) shall be updated as determined appropriate by the Secretary, in consultation with stakeholders. (4) Inclusion of ancillary services Any price or rate for a specified clinical diagnostic laboratory test available to be furnished by an applicable laboratory made publicly available in accordance with paragraph (1) shall include the price or rate (as applicable) for any ancillary item or service (such as specimen collection services) that would normally be furnished by such laboratory as part of such test, as specified by the Secretary. (5) Enforcement (A) In general In the case that the Secretary determines that an applicable laboratory is not in compliance with paragraph (1)— (i) not later than 30 days after such determination, the Secretary shall notify such laboratory of such determination